295
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Systems Biology in Pharmacogenomic Research: The Way to Personalized Prescribing?

, , &
Pages 971-981 | Published online: 17 Jun 2009

Bibliography

  • Maitland-van der Zee AH , BoerwinkleE: Pharmacogenetics of response to statins: where do we stand?Curr. Atheroscler. Rep.7(3) , 204–208 (2005).
  • Drazen JM , SilvermanEK, LeeTH: Heterogeneity of therapeutic responses in asthma.Br. Med. Bull.56(4) , 1054–1070 (2000).
  • Weiss ST , LakeSL, SilvermanES et al.: Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses.Proc. Am. Thorac. Soc.1(4) , 364–367 (2004).
  • Ross JS , FletcherJA, LinetteGP et al.: The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.Oncologist8(4) , 307–325 (2003).
  • Phillips E , MallalS: Drug hypersensitivity in HIV.Curr. Opin. Allergy Clin. Immunol.7(4) , 324–330 (2007).
  • Giacomini KM , BrettCM, AltmanRB et al.: The pharmacogenetics research network: from SNP discovery to clinical drug response.Clin. Pharmacol. Ther.81(3) , 328–345 (2007).
  • McCarthy JJ , HilfikerR: The use of single-nucleotide polymorphism maps in pharmacogenomics.Nat. Biotechnol.18(5) , 505–508 (2000).
  • Evans WE , McLeodHL: Pharmacogenomics – drug disposition, drug targets, and side effects.N. Engl. J. Med.348(6) , 538–549 (2003).
  • Evans WE , RellingMV: Pharmacogenomics: translating functional genomics into rational therapeutics.Science286(5439) , 487–491 (1999).
  • Evans WE , RellingMV: Moving towards individualized medicine with pharmacogenomics.Nature429(6990) , 464–468 (2004).
  • Silverman ES , LiggettSB, GelfandEW et al.: The pharmacogenetics of asthma: a candidate gene approach.Pharmacogenomics J.1(1) , 27–37 (2001).
  • van Schaik RH : CYP450 pharmacogenetics for personalizing cancer therapy.Drug Resist. Updat.11(3) , 77–98 (2008).
  • Wilke RA , LinDW, RodenDM et al.: Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.Nat. Rev. Drug Discov.6(11) , 904–916 (2007).
  • Cho SH , OhSY, BahnJW et al.: Association between bronchodilating response to short-acting β-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene.Clin. Exp. Allergy35(9) , 1162–1167 (2005).
  • Wechsler ME , LehmanE, LazarusSC et al.: β-adrenergic receptor polymorphisms and response to salmeterol.Am. J. Respir. Crit. Care Med.173(5) , 519–526 (2006).
  • Wilke RA , ReifDM, MooreJH: Combinatorial pharmacogenetics.Nat. Rev. Drug Discov.4(11) , 911–918 (2005).
  • Sing CF , StengardJH, KardiaSL: Dynamic relationships between the genome and exposures to environments as causes of common human diseases.World Rev. Nutr. Diet.93 , 77–91 (2004).
  • Moore JH : The ubiquitous nature of epistasis in determining susceptibility to common human diseases.Hum. Hered.56(1–3) , 73–82 (2003).
  • Thornton-Wells TA , MooreJH, HainesJL: Genetics, statistics and human disease: analytical retooling for complexity.Trends Genet.20(12) , 640–647 (2004).
  • Gajendran VK , LinJR, FyhrieDP: An application of bioinformatics and text mining to the discovery of novel genes related to bone biology.Bone40(5) , 1378–1388 (2007).
  • Nenadic G , SpasicI, AnaniadouS: Terminology-driven mining of biomedical literature.Bioinformatics19(8) , 938–943 (2003).
  • Yandell MD , MajorosWH: Genomics and natural language processing.Nat. Rev. Genet.3(8) , 601–610 (2002).
  • Quackenbush J : Extracting meaning from functional genomics experiments.Toxicol. Appl. Pharmacol.207(Suppl. 2) , 195–199 (2005).
  • Davies SM : Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?Hematology Am. Soc. Hematol. Educ. Program111–117 (2006).
  • Ritchie MD : Bioinformatics approaches for detecting gene–gene and gene–environment interactions in studies of human disease.Neurosurg. Focus19(4) , E2 (2005).
  • Moore JH , RitchieMD: STUDENTJAMA. The challenges of whole-genome approaches to common diseases.JAMA291(13) , 1642–1643 (2004).
  • Aderem A : Systems biology: its practice and challenges.Cell121(4) , 511–513 (2005).
  • Dollery CT : Beyond genomics.Clin. Pharmacol. Ther.82(4) , 366–370 (2007).
  • Kirschner MW : The meaning of systems biology.Cell121(4) , 503–504 (2005).
  • Morel NM , HollandJM, van der Greef J et al.: Primer on medical genomics. Part XIV: Introduction to systems biology – a new approach to understanding disease and treatment. Mayo Clin. Proc.79(5) , 651–658 (2004).
  • Shankavaram UT , ReinholdWC, NishizukaS et al.: Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study.Mol. Cancer Ther.6(3) , 820–832 (2007).
  • Riedel RF , PorrelloA, PontzerE et al.: A genomic approach to identify molecular pathways associated with chemotherapy resistance.Mol. Cancer Ther.7(10) , 3141–3149 (2008).
  • Potti A , DressmanHK, BildA et al.: Genomic signatures to guide the use of chemotherapeutics.Nat Med.12(11) , 1294–1300 (2006).
  • Quackenbush J : Microarray analysis and tumor classification.N. Engl. J. Med.354(23) , 2463–2472 (2006).
  • Rice TK , SchorkNJ, RaoDC: Methods for handling multiple testing.Adv. Genet.60 , 293–308 (2008).
  • Li Q , RoxasBA: An assessment of false discovery rates and statistical significance in label-free quantitative proteomics with combined filters.BMC Bioinformatics10(1) , 43 (2009).
  • Cutler DR , EdwardsTC Jr, Beard KH et al.: Random forests for classification in ecology. Ecology88(11) , 2783–2792 (2007).
  • Breiman L : Random Forests.Machine Learning45 , 5–32 (2001).
  • Freund Y , SchapireRE: Experiments with a new boosting algorithm. Proc. 13th International Conference on Machine Learning. Morgan Kaufmann, CA, USA 146–148 (1996).
  • Vapnik VN : An overview of statistical learning theory.IEEE Trans. Neural Netw.10(5) , 988–999 (1999).
  • Gaulton KJ , MohlkeKL, VisionTJ: A computational system to select candidate genes for complex human traits.Bioinformatics23(9) , 1132–1140 (2007).
  • Yu S , Van Vooren S, Tranchevent LC, De Moor B, Moreau Y: Comparison of vocabularies, representations and ranking algorithms for gene prioritization by text mining. Bioinformatics24(16) , I119–I125 (2008).
  • Xu Z , KaplanNL, TaylorJA: Tag SNP selection for candidate gene association studies using HapMap and gene resequencing data.Eur. J. Hum. Genet.15(10) , 1063–1070 (2007).
  • Xu H , GregorySG, HauserER et al.: SNPselector: a web tool for selecting SNPs for genetic association studies.Bioinformatics21(22) , 4181–4186 (2005).
  • Sherry ST , WardMH, KholodovM et al.: dbSNP: the NCBI database of genetic variation.Nucleic Acids Res.29(1) , 308–311 (2001).
  • Bhatti P , ChurchDM, RutterJL, StruewingJP, SigurdsonAJ: Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists.Am. J. Epidemiol.164(8) , 794–804 (2006).
  • Stram DO : Tag SNP selection for association studies.Genet. Epidemiol.27(4) , 365–374 (2004).
  • Erinjeri JP , PicusD, PriorFW, RubinDA, KoppelP: Development of a google-based search engine for data mining radiology reports.J. Digit. Imaging (2008) (Epub ahead of print).
  • Hopkins AL : Network pharmacology: the next paradigm in drug discovery.Nat. Chem. Biol.4(11) , 682–690 (2008).
  • Pearl J : Probabilistic Reasoning in Intelligent Systems: Networks of Plausible Inference. Morgan Kaufmann Publishers, CA, USA (1988).
  • Rodin AS , BoerwinkleE: Mining genetic epidemiology data with Bayesian networks I: Bayesian networks and example application (plasma apoE levels).Bioinformatics21(15) , 3273–3278 (2005).
  • Needham CJ , BradfordJR, BulpittAJ, WestheadDR: A primer on learning in Bayesian networks for computational biology.PLoS Comput. Biol.3(8) , E129 (2007).
  • Wilczynski B , DojerN: BNFinder: exact and efficient method for learning Bayesian networks.Bioinformatics25(2) , 286–287 (2008).
  • Friedman N , LinialM, NachmanI, Pe‘erD: Using Bayesian networks to analyze expression data.J. Bioinform. Comput. Biol.7(3/4) , 601–620 (1998).
  • Djebbari A , QuackenbushJ: Seeded Bayesian networks: constructing genetic networks from microarray data.BMC Syst. Biol.2 , 57 (2008).
  • Motsinger AA , RitchieMD: Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene–gene interactions in human genetics and pharmacogenomics studies.Hum. Genomics2(5) , 318–328 (2006).
  • Ritchie MD , HahnLW, RoodiN et al.: Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.Am. J. Hum. Genet.69(1) , 138–147 (2001).
  • Motsinger-Reif AA , ReifDM, FanelliTJ, RitchieMD: A comparison of analytical methods for genetic association studies.Genet. Epidemiol. (2008) (Epub ahead of print).
  • Kiechle FL , ZhangX, Holland-StaleyCA: The -omics era and its impact.Arch. Pathol. Lab. Med.128(12) , 1337–1345 (2004).
  • Yan Q : Pharmacogenomics in drug discovery and development. Preface.Methods Mol. Biol.448 , V–VII (2008).
  • Yan Q : Pharmacogenomics of membrane transporters an overview.Methods Mol. Biol.227 , 1–20 (2003).
  • Davidov EJ , HollandJM, MarpleEW, NaylorS: Advancing drug discovery trhough systems biology.Drug Discov. Today8(4) , 175–183 (2003).
  • Terrett NK , BellAS, BrownD, EllisP: Sildenafil (viagra), a potent and selective inhibitor of type 5 CGMP phosphodiesterase with utility for the treatment of male erectile dysfunction.Bioorg. Med. Chem. Lett.6(15) , 1819–1824 (1996).
  • Capdeville R , BuchdungerE, ZimmermannJ, MatterA: Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.Nat. Rev. Drug Discov.1(7) , 493–502 (2002).
  • Mathew SJ , ManjiHK, CharneyDS: Novel drugs and therapeutic targets for severe mood disorders.Neuropsychopharmacology33(9) , 2080–2092 (2008).
  • Srinivasan BS , ShahNH, FlannickJA, AbeliukE, NovakAF, BatzoglouS: Current progress in network research: toward reference networks for key model organisms.Brief Bioinform.8(5) , 318–332 (2007).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.